Key findings from the SURMOUNT-OSA trial The SURMOUNT-OSA trial evaluated tirzepatide versus placebo in adults with moderate-to-severe OSA (AHI 15) and obesity, including both CPAP users and non-users
For all-cause mortality, the five-year survival probability was 96.9% with GLP-1RAs and 82.3% with insulin/metformin
Prioritizing calorie-dense, nutrient-rich foods at every meal
While the body can produce its glutathione, certain factors such as aging, stress, and exposure to toxins can deplete the body's stores
Jie HW, Jie W, Jianxiong M, Xin Z, Runnan X, Yijia F, et al
Anyone with a chronic health condition, anyone taking regular medications, and anyone considering intravenous therapy should speak with a doctor first